Amplia Therapeutics Limited (ASX:ATX)
Australia · Delayed Price · Currency is AUD 0.1250
+0.0050 (4.17%)
Sep 11, 2026, 11:33 AM AEST
Amplia Therapeutics Market Cap
Amplia Therapeutics has a market cap or net worth of 61.6 million as of September 10, 2026. Its market cap has decreased by -27.24% in one year.
Market Cap
61.60M
Enterprise Value
34.08M
Revenue
4.79M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.13
ChartMarket Cap Chart
Since December 23, 2013, Amplia Therapeutics's market cap has increased from 34.50M to 61.60M, an increase of 78.56%. That is a compound annual growth rate of 4.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 61.60M | -19.96% |
| Dec 31, 2025 | 76.96M | 122.90% |
| Dec 31, 2024 | 34.53M | 122.47% |
| Dec 28, 2023 | 15.52M | - |
| Dec 29, 2022 | 15.52M | -51.48% |
| Dec 31, 2021 | 31.99M | 24.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 110.34M |
| Recce Pharmaceuticals | 108.55M |
| Avecho Biotechnology | 88.87M |
| LTR Pharma | 84.53M |
| Arovella Therapeutics | 72.53M |
| Entropy Neurodynamics | 68.57M |
| Prescient Therapeutics | 68.35M |
| Immutep | 67.79M |